←
Kaushik Amancherla191 posts
Kaushik Amancherla avatar

Kaushik Amancherla

@KAmancherla

Advanced HF & Transplant Cardiologist at Vandy @vumc_heart, Osler alum @OslerResidency #Thayer. Tweets = my own opinions =/= medical advice.

◷ Joined December 2011▧ 6 Photos and videos
Kaushik Amancherla avatar
Kaushik Amancherla@KAmancherla·Oct 13

Excited to see our review out! Thank you to @JAMA_current and my co-authors. We hope this helps anyone who takes care of HF patients on when to refer for advanced therapy eval and what happens after heart transplant.

#JAMAReview: Among adults undergoing #HeartTransplant, contemporary survival is high, but long-term outcomes depend on surveillance for rejection and #cardiac allograft #vasculopathy and careful management of #immunosuppression-related complications. 🔗 ja.ma/4hQQNXM

Post attachment
Kaushik Amancherla avatar
Kaushik Amancherla@KAmancherla·Aug 12

• Should we be predicting response to therapy, not simply diagnosing rejection? And should this be linked to a pathologic diagnosis? • Could spatial molecular phenotyping eventually help choose the right immunomodulatory therapy for the right patient?

Kaushik Amancherla avatar
Kaushik Amancherla@KAmancherla·Aug 12

A few questions this leaves me thinking about: • Is histologic rejection grade the disease or a visible phenotype of several molecular diseases? • Does “resolved rejection” on histology necessarily mean molecular resolution?

Kaushik Amancherla avatar
Kaushik Amancherla@KAmancherla·Aug 12

We also identified cell-specific expression programs associated with later CAV & observed similar programs in hearts with severe CAV. This raises a bigger question: Does an episode of acute rejection leave a molecular footprint that contributes to chronic graft injury?

Kaushik Amancherla avatar
Kaushik Amancherla@KAmancherla·Aug 12

Perhaps the most clinically provocative finding: Before treatment, biopsies from eventual responders vs nonresponders already looked different transcriptionally. Could we eventually predict which rejection will be treatment-resistant before giving therapy?

Kaushik Amancherla avatar
Kaushik Amancherla@KAmancherla·Aug 12

Spatial context added another layer. Rejection involved coordinated immune, vascular and stromal programs - not simply “more T cells” or “more antibodies.” Different forms of rejection showed distinct cellular neighborhoods and cell-specific transcriptional programs.

Kaushik Amancherla avatar
Kaushik Amancherla@KAmancherla·Aug 12

We mapped >160,000 cells across 62 adult + pediatric HT recipients during rejection and after treatment. The first message was striking: Histologically similar rejection can be molecularly very different. ACR/AMR or rejection grade captured only part of the underlying biology.

Kaushik Amancherla avatar
Kaushik Amancherla@KAmancherla·Aug 12

🫀 What if the same histologic grade of heart transplant rejection does not represent the same disease? Our new study in @NatureCVR used single-cell spatial transcriptomics in serial cardiac allograft biopsies to answer this question. rdcu.be/fzvkC

JHLT avatar
⟳ Kaushik Amancherla retweeted
JHLT@TheJHLT·Mar 10

In this single-center analysis, adult females were found to be less likely to develop #CAV following #HeartTx while adult male recipients demonstrated an upregulation of inflammatory/autoimmune pathways favoring CAV development. @KAmancherla 🔗: jhltonline.org/article/S1053…